Treatment Selection in Ulcerative Colitis: Optimizing Outcomes through Patient-Centered Decision Making
Podcast 2: Assessment of Bowel Urgency in UC Clinical Trials
Post-Test/Evaluation

Questions marked with a * are required

20%

Contact Information

First Name

Last Name

Email Address

Credentials/Degree (MD, DO, RN, etc.)

Date of Participation

An analysis of the results of the LUCENT-1 and LUCENT-2 clinical trials investigating the safety and efficacy of mirikizumab in patients with UC, demonstrated that patients who achieved clinically meaningful improvement of bowel urgency also had higher rates of:

Clinical remission

Corticosteroid-free remission

Endoscopic remission

All of the above

A teenage female patient recently diagnosed with ulcerative colitis presents to your office with her mother for a follow-up appointment to discuss her response to treatment with mesalamine 4.8 g/d. It is clear the patient is embarrassed and reluctant to talk about her symptoms. Her mother shares that her daughter has been experiencing increased bowel urgency and must wear protective undergarments while at school. Which of the following is the most appropriate method to assess bowel urgency in ulcerative colitis?

UNRS

PRO-2

Endoscopic examination

None of the above